BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24478024)

  • 1. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
    de Groen FL; Krijgsman O; Tijssen M; Vriend LE; Ylstra B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
    Genes Chromosomes Cancer; 2014 Apr; 53(4):339-48. PubMed ID: 24478024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
    de Groen FL; Timmer LM; Menezes RX; Diosdado B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
    PLoS One; 2015; 10(7):e0132495. PubMed ID: 26148070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Fijneman RJ; Meijer GA
    J Pathol; 2012 Feb; 226(3):442-50. PubMed ID: 22009326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
    PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
    Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
    Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.
    Zarzour P; Boelen L; Luciani F; Beck D; Sakthianandeswaren A; Mouradov D; Sieber OM; Hawkins NJ; Hesson LB; Ward RL; Wong JW
    Genes Chromosomes Cancer; 2015 May; 54(5):303-14. PubMed ID: 25726927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
    Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature.
    Martens-de Kemp SR; Komor MA; Hegi R; Bolijn AS; Tijssen M; de Groen FLM; Depla A; van Leerdam M; Meijer GA; Fijneman RJA; Carvalho B
    Neoplasia; 2022 Oct; 32():100820. PubMed ID: 35872559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of gene expression and chromosomal abnormalities in colorectal cancer.
    Tsafrir D; Bacolod M; Selvanayagam Z; Tsafrir I; Shia J; Zeng Z; Liu H; Krier C; Stengel RF; Barany F; Gerald WL; Paty PB; Domany E; Notterman DA
    Cancer Res; 2006 Feb; 66(4):2129-37. PubMed ID: 16489013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.
    Diosdado B; van de Wiel MA; Terhaar Sive Droste JS; Mongera S; Postma C; Meijerink WJ; Carvalho B; Meijer GA
    Br J Cancer; 2009 Aug; 101(4):707-14. PubMed ID: 19672269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
    Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
    Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms.
    Richter H; Slezak P; Walch A; Werner M; Braselmann H; Jaramillo E; Ost A; Hirata I; Takahama K; Zitzelsberger H
    Am J Pathol; 2003 Jul; 163(1):287-94. PubMed ID: 12819033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
    Carvalho B; Sillars-Hardebol AH; Postma C; Mongera S; Terhaar Sive Droste J; Obulkasim A; van de Wiel M; van Criekinge W; Ylstra B; Fijneman RJ; Meijer GA
    Cell Oncol (Dordr); 2012 Feb; 35(1):53-63. PubMed ID: 22278361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
    Di Renzo MF; Olivero M; Giacomini A; Porte H; Chastre E; Mirossay L; Nordlinger B; Bretti S; Bottardi S; Giordano S
    Clin Cancer Res; 1995 Feb; 1(2):147-54. PubMed ID: 9815967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer.
    Pan Y; Tong JHM; Kang W; Lung RWM; Chak WP; Chung LY; Wu F; Li H; Yu J; Chan AWH; To KF
    Mol Carcinog; 2018 Dec; 57(12):1780-1791. PubMed ID: 30155936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.
    Hermsen M; Postma C; Baak J; Weiss M; Rapallo A; Sciutto A; Roemen G; Arends JW; Williams R; Giaretti W; De Goeij A; Meijer G
    Gastroenterology; 2002 Oct; 123(4):1109-19. PubMed ID: 12360473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.